Actively Recruiting
Harm Reduction Services
Led by NYU Langone Health · Updated on 2026-03-19
200
Participants Needed
3
Research Sites
174 weeks
Total Duration
On this page
Sponsors
N
NYU Langone Health
Lead Sponsor
N
National Institute of General Medical Sciences (NIGMS)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to assess whether an integrated harm reduction intervention (IHRI), compared to harm reduction (HR) services as usual, will improve harm reduction service utilization among Black and Latinx people who use drugs (PWUD).
CONDITIONS
Official Title
Harm Reduction Services
Who Can Participate
Eligibility Criteria
You may qualify if you...
- At least 18 years of age
- Self-identified as misusing opioids with or without other substances (stimulants) in the past 30 days, confirmed by interview using DSM-5 criteria
- English or Spanish speaking
- Able to provide informed consent
You will not qualify if you...
- Unable to provide informed consent or participate in study procedures
- Active suicidal or homicidal thoughts or unstable psychotic or severe mood disorders
- Unwilling to be randomized
- Currently a prisoner
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Yale University
New Haven, Connecticut, United States, 06520
Actively Recruiting
2
NYU Langone Health
New York, New York, United States, 10016
Not Yet Recruiting
3
Nathan Kline Institute
Orangeburg, New York, United States, 10962
Actively Recruiting
Research Team
A
Ayana Jordan, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here